'For good technology investments, benefits and cost-efficiencies outweigh cost factors overtime'
BioSpectrum Asia|BioSpectrum Asia Sep 2021
Recent innovations in the industry are, demonstrably, supporting hospitals and healthcare workers in planning for safer and more efficient use of their resources, while minimising waste. Better still, these systems can even help prevent the spread of viruses in hospitals where frontline workers are at great risk. With the increasing concerns around the Asia Pacific (APAC) region, BioSpectrum Asia spoke to healthcare expert, Dirk Dumortier, Head of Business Development Smart-City and Healthcare (Asia Pacific), Alcatel-Lucent Enterprise (ALE), Singapore on prospects and gateways towards progressive healthcare system for Asia-Pacific regions. Edited excerpts;
- Hithaishi C Bhaskar
'For good technology investments, benefits and cost-efficiencies outweigh cost factors overtime'

Dirk Dumortier, Head of Business Development Smart-City and Healthcare (Asia Pacific), Alcatel-Lucent Enterprise, Singapore

Could you brief South East Asia’s healthcare exigency and enduring strategies to build a resilient model?

The global pandemic has exerted considerable stress on our healthcare system and exposed fundamental challenges that need to be resolved urgently. In countries across Southeast Asia battling a resurgence of the COVID-19 virus spread, hospitals are grappling with a widespread shortage of medical resources and trained staff. Front-liners are faced with the herculean task of delivering patient care while managing administrative tasks.

Meanwhile, we also see countries like Singapore struggling with rising healthcare bills due to increased resource consumption, exacerbated by the pandemic and a rapidly ageing population.

It is crucial that healthcare organisations look immediately into enduring strategies to boost their resilience for the long fight ahead. Healthcare organisations must consider how they can digitalise and adopt technologies to cope with rising costs, better manage resources and create a more efficient and safer environment for patients and staff.

Only then, can we prevail in the battle of endurance against the pandemic, as well as be better equipped to weather future crises.

What are the common hurdles in introducing technology to the industry, and how can these be overcome?

The first hurdle to any technology investment decision is usually cost. Decision makers at healthcare organisations may also be concerned with longer-term requirements, such as IT and support teams, maintenance, and upkeep.

この蚘事は BioSpectrum Asia の BioSpectrum Asia Sep 2021 版に掲茉されおいたす。

7 日間の Magzter GOLD 無料トラむアルを開始しお、䜕千もの厳遞されたプレミアム ストヌリヌ、9,000 以䞊の雑誌や新聞にアクセスしおください。

この蚘事は BioSpectrum Asia の BioSpectrum Asia Sep 2021 版に掲茉されおいたす。

7 日間の Magzter GOLD 無料トラむアルを開始しお、䜕千もの厳遞されたプレミアム ストヌリヌ、9,000 以䞊の雑誌や新聞にアクセスしおください。

BIOSPECTRUM ASIAのその他の蚘事すべお衚瀺
Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time
BioSpectrum Asia

Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time

US-based Promega Corporation, a life-sciences research partner dedicated to providing intuitive tools that empower scientists to innovate, has unveiled the new GloMax Galaxy Bioluminescence Imager.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Singleron and Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers
BioSpectrum Asia

Singleron and Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers

Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Eppendorf brings CO2 incubator shaker with integrated 180 °C sterilisation routine
BioSpectrum Asia

Eppendorf brings CO2 incubator shaker with integrated 180 °C sterilisation routine

Eppendorf has announced the launch of a CO2 incubator shaker with integrated 180 °C sterilisation routine.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Waters introduces new bioseparations tools to improve development of RNA-based vaccines using LC-MS analysis
BioSpectrum Asia

Waters introduces new bioseparations tools to improve development of RNA-based vaccines using LC-MS analysis

US-based Waters Corporation has introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify sequence and modification confirmation of large molecule RNA therapeutics using liquid chromatography-mass spectrometry (LCMS) analysis.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Singapore designs novel gene therapy offering hope for epilepsy patients
BioSpectrum Asia

Singapore designs novel gene therapy offering hope for epilepsy patients

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore are working on a therapy that holds potential in treating patients with epilepsy, a neurological disorder defined by recurring seizures due to abnormal brain activity.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Spider venom heart drug moves to clinical trials in Australia
BioSpectrum Asia

Spider venom heart drug moves to clinical trials in Australia

A University of Queensland (UQ)-led project in Australia to develop the first-ever drug to treat heart attack and protect donor hearts will move to human clinical trials, after receiving $17.8 million in funding from the Medical Research Future Fund (MRFF).

time-read
1 min  |
BioSpectrum Asia Nov 2024
India develops portable ultrasound scanner for sports injury diagnosis
BioSpectrum Asia

India develops portable ultrasound scanner for sports injury diagnosis

A team of researchers at the Indian Institute of Technology Madras (IIT-M) has developed an indigenous portable Point-of-CareUltrasound (POCUS) Scanner for sports injury diagnosis and management.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Integris appoints medtech veteran Probir Das as new CEO
BioSpectrum Asia

Integris appoints medtech veteran Probir Das as new CEO

Integris Healthcare, a global diversified medical technology company, has announced the appointment of Probir Das as Chief Executive Officer (CEO). He will join effective November 2024 and will be based in New Delhi.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Clarity Pharma promotes Michelle Parker to CEO
BioSpectrum Asia

Clarity Pharma promotes Michelle Parker to CEO

Australia-based Clarity Pharmaceuticals has announced the appointment of Michelle Parker as Chief Executive Officer (CEO), effective from October 11, 2024.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Dr Makoto Sugita steps in as President of Nxera Pharma Japan
BioSpectrum Asia

Dr Makoto Sugita steps in as President of Nxera Pharma Japan

Nxera Pharma Co., formerly known as Sosei Group or Sosei Heptares, has announced the appointment of Dr Makoto Sugita, as President of Nxera Pharma Japan, and Executive Officer, Executive Vice President and Chief Medical Officer (CMO) of Nxera Pharma.

time-read
1 min  |
BioSpectrum Asia Nov 2024